Cannabis in Mexico

Mexico's cannabis landscape is characterized by a constitutional court ruling that effectively decriminalized personal use, combined with a stalled legislative process for creating a regulated commercial market. In 2017, Mexico legalized medical cannabis through amendments to the General Health Law, permitting the use of cannabis-based medicines with less than 1% THC. The Supreme Court subsequently ruled in a series of decisions between 2015 and 2019 that the prohibition on personal recreational cannabis use was unconstitutional.

In 2021, the Supreme Court formally invalidated the prohibition on personal recreational cannabis use, setting a deadline for Congress to pass implementing legislation. Despite this mandate, the Mexican Congress has repeatedly failed to pass comprehensive cannabis legalization legislation, with proposed bills stalling amid disagreements over market structure, licensing, social equity, and the role of traditional growers. Multiple draft bills have been introduced but none have been enacted as of early 2026.

The regulatory framework for medical cannabis was finalized in January 2021, establishing permits for cultivation, processing, and sale of medical cannabis products. However, implementation has been slow, with relatively few permits issued. The Mexican medical cannabis market remains small compared to its potential given the country's population of 130 million.

Mexico's strategic position as a potential legal cannabis market is enormous. With the largest Spanish-speaking population in the world and proximity to the US market, a fully regulated Mexican cannabis industry could become one of the world's largest. However, security concerns, cartel involvement in illicit cannabis production, and political uncertainty continue to complicate the path to full commercialization.